Healthcare: How Doctors Treat Dementia and Lung Cancer Could Be About to Change

Industry Focus - Podcast tekijän mukaan The Motley Fool

Kategoriat:

Acadia Pharmaceuticals' dementia-related psychosis trial offers new hope to patients diagnosed with Alzheimer's disease.  Also, results from a lung cancer trial just strengthened Eli Lilly's leadership in precision medicine. Stocks: ACAD, LLY

Visit the podcast's native language site